Epi-LASIK is a refractive procedure performed with an epikeratome which mechanically cleaves the epithelium from the Bowman’s membrane, leaving a pristine optical zone for laser ablation. The epithelial flap can then either be discarded or repositioned, according to the surgeon’s preference.

Many surgeons have made Epi-LASIK their procedure of choice for surface ablation. With the Epi-KTM MORIA epikeratome, and the latest refinements in technique and postoperative care, Epi-LASIK produces faster healing and visual recovery than all other surface ablation procedures.


Descemets’ Stripping Automated Endothelial Keratoplasty (DSAEK) for Fuchs’ and other endothelial dystrophies (i.e. posterior polymorphous dystrophy), post-cataract surgery edema (aphakic or pseudophakic bullous keratopathy) and some of failed PK.

Superficial Anterior Lamellar Keratoplasty (SALK) indicated in the treatment of superficial corneal opacities resulting from previous refractive surgical procedures, infections, degenerations, dystrophies, superficial scars or trauma.

Deep Anterior Lamellar Keratoplasty (DALK) indicated when a thicker stromal lamella should be removed: keratoconus, post-herpetic scars, post-infectious opacities, some corneal dystrophies, and alkali or acid burn lesions.

Mushroom and Lap joint Keratoplasty indicated in patients with full-thickness central stromal opacities but normal endothelium.

lntacs® for KERATONOCUS

A new standard of care is fast becoming the preferred treatment for patients suffering from keratoconus. lntacs® corneal implants can now potentially defer the need for a corneal transplant. Historically, physicians and patients didn’t have a choice. Once a patient becomes intolerant of contact lenses or glasses, their only option has been to undergo a corneal transplant. Today, surgeons around the world are choosing a less invasive standard of care and achieving excellent results with lntacs® corneal implants.

  • Restores contact lens tolerance by creating a more natural prolate corneal shape.
  • Excellent safety record, with an exceptionally low complaint level.
  • The implant of choice to manage the widest spectrum of keratoconic patients.
  • Fast, minimally invasive procedure.
  • Performed with world-class set of instruments producing highly consistent results.
  • Clinically established refractive change of between 2 to 12 diopters- UCVA and BCVA.
  • Supported by over 100 peer-reviewed articles since 2001 .
  • Implanted outside of central optical zone, with low incidence of visual symptoms after surgery.
  • Security of removablility and replaceability with no reported risk of further complications.
  • lntacs® are registered in over sixty countries, FDA approved & have a European CE Mark.


Quality of Life for Your Patient.

lntacs® corneal implants delay a corneal transplant indefinitely, restore contact lens tolerance and in most instances provide improvement in best corrected visual acuity. For the keratoconus patient having 20/40 vision only a few hours a day due to painful contact lens wear, lntacs corneal implants are a new standard of care. In the only Quality of Vision study ever published with corneal implants, nearly 50% of lntacs® patients rated their vision Good to Excellent as compared to only 10% preoperatively with contacts, and 90% rated their vision Fair to Excellent compared with a 70% preoperative rating of Poor.(1)

Reference (1) Cohn J. lntacs and Keratoconus Treatment. J Cataract Refract Surg 2006; 32:747-755